4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs

NCT06553547 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome With Constipation (IBS-C)

Interventions

DRUG: Tenapanor
DRUG: Placebo

Sponsor

Ardelyx